Neurocrine Biosciences, Inc. (NBIX)
Free
No email, no account, no signup.
Pulling latest news for Neurocrine Biosciences, Inc.…
Bull
Bear
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report –
Order analysis – $4.99 $1.25
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology and neuroscience
Market Cap
$14.5B
Market sentiment
Sentiment has improved on the closed Soleno deal, recurring data readouts/presentations, and a wave of analyst price-target increases; social chatter is more technical but broadly constructive.
Why BUY ?
Closing the deal reduces transaction uncertainty and broadens the revenue story with a new rare-disease asset, while the core franchise continues to show strong growth and supportive data points. With sentiment improving and clear catalysts into Q2, the risk/reward now favors adding rather than waiting.
- ADD: scale in ahead of the Q2 print, while planning for volatility around integration execution and pricing commentary.
We're already tracking Neurocrine Biosciences, Inc. — here are the latest events we've registered
Recent News
- Since May 6, Neurocrine completed the acquisition of Soleno Therapeutics (VYKAT™ XR for hyperphagia in Prader-Willi syndrome), shared additional INGREZZA and CRENESSITY data, and participated in investor conferences. Multiple banks also raised price targets/reiterated positive ratings across May–June.
Want to know how this news affects Neurocrine Biosciences, Inc.? Order the analysis.
Order analysis – Catalysts
30 Jul 2026 — Q2 2026 earnings (incl. first Soleno contribution)
Order analysis – $4.99 $1.25
Save hours of research. $4.99 $1.25.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Sources: news, filings, market data, and investor forums
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Neurocrine Biosciences, Inc. will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.